MCFinancial Services · Capital MarketsThe 11 Wall Street analysts covering Moelis & Co. hold a median 12-month price target of $67 — +14.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 54 of 100 as at 29 Oct 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Moelis & Co. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (100): The business earns solid, repeatable profits on what it owns.
Accruals (29): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (23): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on MC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +14.4% from it.
Of the 20 most recent actions, 2 moved their price target up and 5 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 27 Oct 2026 | JP Morgan | Maintains | Neutral | $70 → $68 |
| 8 Oct 2026 | Morgan Stanley | Maintains | Overweight | $85 → $77 |
| 8 Oct 2026 | Morgan Stanley | Maintains | Overweight | — |
| 7 Oct 2026 | UBS | Upgrade | Neutral | — |
| 7 Oct 2026 | UBS | Upgrade | Neutral | $60 → $59 |
| 1 Oct 2026 | Goldman Sachs | Maintains | Neutral | $71 → $62 |
| 1 Oct 2026 | Goldman Sachs | Maintains | Neutral | — |
| 30 July 2026 | Morgan Stanley | Maintains | Overweight | — |
| 30 July 2026 | Morgan Stanley | Maintains | Overweight | $83 → $85 |
| 10 July 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | — |
| 10 July 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $69 → $66 |
| 8 July 2026 | UBS | Downgrade | Sell | $58 → $60 |
| 8 July 2026 | UBS | Downgrade | Sell | — |
| 9 Apr 2026 | Morgan Stanley | Maintains | Overweight | — |
| 8 Apr 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | — |
| 8 Apr 2026 | UBS | Maintains | Neutral | — |
| 1 Apr 2026 | Goldman Sachs | Maintains | Neutral | — |
| 12 Mar 2026 | Goldman Sachs | Maintains | Neutral | — |
| 12 Mar 2026 | UBS | Maintains | Neutral | — |
| 5 Feb 2026 | JP Morgan | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
MC appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 30 Oct 2026, Moelis & Co. returned −5.2% against +12.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 38% of US stocks
Cheaper than 44% of US stocks
Cheaper than 11% of US stocks
Cheaper than 23% of US stocks
Higher than 58% of US stocks
Higher than 56% of US stocks
Higher than 41% of US stocks
Higher than 76% of US stocks
Higher than 77% of US stocks
Higher than 92% of US stocks
Higher than 98% of US stocks
Higher than 92% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Moelis & Co. has a market value of $4.4B and an enterprise value of $4.6B.
Revenue in the twelve months to 30 June 2026: $1.6B. The latest quarter grew 12.0% year on year.
Net income over the same four quarters: $256.5M, a 16.3% net margin.
Diluted earnings per share, trailing twelve months: $2.87.
Free cash flow in the twelve months to 30 June 2026: $433.4M.
Moelis & Co. spent $202.1M on share buybacks and $217.2M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 20.3×; forward P/E: 15.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 4.46%, paying out 91% of earnings.
Moelis & Co. employs 1,416 people — $1.1M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Moelis & Co. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research says Moelis has two key ingredients associated with a likely earnings beat in its upcoming report and highlights expectations for the report.
Why it matters — MC watchers may note the article’s focus on expectations for Moelis’s upcoming earnings report.
Moelis & Company said it will announce its third-quarter 2026 financial results and host a conference call on November 5, 2026.
Why it matters — The announcement gives MC watchers the date when the company plans to report results and discuss them on a conference call.
Moelis & Company reported Q2 earnings that beat estimates, with revenues increasing 12% driven by higher average fees per completed transaction, despite higher expenses.
Why it matters — An earnings beat driven by revenue growth signals improved deal-making activity and fee generation, which are core to MC's advisory business.
Moelis & Company reported record second-quarter and first-half revenue for 2026, driven by higher average fees per completed transaction and growth in its capital markets and private capital advisory businesses.
Why it matters — The record revenue signals strong operational momentum in Moelis's core advisory and capital markets segments.
Moelis & Company held its Q2 2026 earnings call, and the transcript of the call was published by Seeking Alpha.
Why it matters — Earnings call transcripts offer detailed management commentary on quarterly financial performance and strategic outlook.
The 11 Wall Street analysts covering Moelis & Co. have a median 12-month price target of $67, with estimates ranging from $58 to $80. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 11 analysts covering Moelis & Co., 4 rate it a Buy, 6 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Moelis & Co. 54 out of 100 across roughly 4,600 US stocks as at 29 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 29 Oct 2026, Moelis & Co. ranks 54 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (100 of 100).
No one can know that. What the data says: the median 12-month target from 11 analysts implies +14.4% from the last close, and Ticker Nerd's factor model ranks Moelis & Co. 54 out of 100 as at 29 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Moelis & Co. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $58 to $80 over the next 12 months.
Moelis & Co. returned -5.2% over the 12 months to 30 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Moelis & Company is an independent investment banking advisory firm that provides strategic and financial advice to corporations, governments, financial sponsors, entrepreneurs, and sovereign wealth funds. Moelis & Company focuses on mergers and acquisitions, recapitalizations, restructurings, capital markets transactions, capital structure advisory, strategic advisory, and private capital advisory.
The most recent item we track (Zacks Investment Research, 29 Oct 2026): "Moelis (MC) Earnings Expected to Grow: Should You Buy?". Zacks Investment Research says Moelis has two key ingredients associated with a likely earnings beat in its upcoming report and highlights expectations for the report.
Moelis & Company is an independent investment banking advisory firm that provides strategic and financial advice to corporations, governments, financial sponsors, entrepreneurs, and sovereign wealth funds. Moelis & Company focuses on mergers and acquisitions, recapitalizations, restructurings, capital markets transactions, capital structure advisory, strategic advisory, and private capital advisory. The firm serves clients across North and South America, Europe, the Middle East, Asia, and Australia, working across a broad range of industries and transaction types. Its business model centers on delivering specialized advisory services rather than underwriting or commercial banking, giving it a focused role in complex corporate finance decisions. Headquartered in New York, Moelis & Company is recognized in the financial market as a global advisory platform with a diversified client base and an emphasis on high-value, tailored transaction support.
CEO Mr. Navid Mahmoodzadegan J.D. · 1,416 employees · United States · https://www.moelis.com
